Researchers remark that their findings “raise concerns about competition and call for closer scrutiny by the Federal Trade Commission, state regulators and policy makers.”
A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.
A joint announcement from the DOJ, FTC and HHS asks for providers, patients or other industry experts to share their experiences with private equity transactions, including those not typically subject to antitrust review by law.
Medicare Advantage covers a disproportionate share of disadvantaged senior citizens compared with traditional fee-for-service Medicare, yet the former bests the latter on some key outcomes metrics.
Pricing transparency report cards for 2024 are out, and the grades for U.S. hospitals have dipped for the first time since the federal government reset the standards in 2021.
As the tsunami of the Change Healthcare cyberattack continues to inundate the healthcare landscape, the AMA and AHA have sent separate letters to federal officials calling for a lifesaver.
Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift.
As healthcare AI opens new avenues to improve care quality without unduly increasing operational costs, the technology also expands potential exposure to civil and criminal liabilities. And that’s not only for providers but also payers and suppliers.
